Home > PJ (current issue) > The Society / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7456 p716
16 June 2007


Society summary


Quality management feasibility study for the preregistration scheme

The Royal Pharmaceutical Society is to carry out a quality management feasibility study for its preregistration scheme.

A proposal from the Education Committee was agreed at the June Council meeting. The meeting was advised that providing a quality assurance scheme for the preregistration year was an obligation under the Pharmacists and Pharmacy Technicians Order 2007 and that primary care trusts (PCTs) and strategic health authorities (SHAs) were taking an interest.

Presenting the proposal, Graham Phillips said there were three possible approaches. One of these was a centralised scheme run entirely by the Society, which would have the advantage of centralised control and the disadvantages of that in terms of cost and local engagement. Another approach, at the other extreme, would be a scheme run entirety by PCTs and SHAs, which might be too distant from the Society and not meet its obligations under the Order.

A third way was a quality managed scheme run through a partner body such as a deanery with Society oversight. That was the Education Committee’s preferred option for the basis of a pilot study. It controlled costs and met the Society’s obligations. A deanery was an existing infrastructure delivering quality management and quality assurance in education. The committee recommended the West Midlands Deanery as partner because of its enthusiasm and its desire to be involved. It already had a pharmacy input and it had a proven track record in training doctors.

The Council agreed to set up a steering group with representation from the Society, the deanery, local employers and local schools of pharmacy. The plan was to commence the pilot in January 2008.

During discussion on the proposal, John Jolley raised the issue of preregistration training for pharmacists in the industry. Preregistration training could only be carried out through community or hospital practice, and this had resulted in a significant reduction in numbers of industrial pharmacists. He urged the Council to look for a way to devise appropriate preregistration training for industrial pharmacy, Sue Kilby, supporting Mr Jolley, said that the West Midlands was an area that had no industrial pharmacists. Once the pilot scheme was expanded to cover other areas, it needed to involve preregistration tutors within the industry.

Back to Top


©The Pharmaceutical Journal